We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. From real world data to real world evidence to improve outcomes in neuro-ophthalmology

    Real-world data (RWD) can be defined as all data generated during routine clinical care. This includes electronic health records, disease-specific...

    Blake D. Colman, Zhuoting Zhu, ... Anneke van der Walt in Eye
    Article Open access 06 June 2024
  2. A step-by-step guide to causal study design using real-world data

    Due to the need for generalizable and rapidly delivered evidence to inform healthcare decision-making, real-world data have grown increasingly...

    Sarah Ruth Hoffman, Nilesh Gangan, ... Michael Grabner in Health Services and Outcomes Research Methodology
    Article Open access 19 June 2024
  3. The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

    Objectives

    The S-REAL study aimed to assess the effectiveness of durvalumab as consolidation therapy after definitive chemoradiotherapy (CRT) in a...

    Ana Gómez Rueda, Álvaro Taus, ... Pilar Garrido in Clinical and Translational Oncology
    Article 21 March 2024
  4. Von Real-World-Daten zur Real-World-Evidenz: eine praktische Anleitung

    Background

    Real-world evidence (RWE), the understanding of treatment effectiveness in clinical practice generated from longitudinal patient-level data...

    Sebastian Schneeweiss in Prävention und Gesundheitsförderung
    Article Open access 12 April 2023
  5. Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study

    Genomic prediction of antipsychotic dose and polypharmacy has been difficult, mainly due to limited access to large cohorts with genetic and drug...

    Elise Koch, Anders Kämpe, ... Ole A. Andreassen in Neuropsychopharmacology
    Article 06 January 2024
  6. Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study

    Introduction

    In this phase 4, multicentre, prospective, non-interventional PIONEER REAL Netherlands study, we assessed clinical outcomes associated...

    William van Houtum, Patrick Schrömbges, ... Hans Herrings in Diabetes Therapy
    Article Open access 11 June 2024
  7. Alzheimer’s Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab

    Background

    Linking data from clinical trials and real-world claims may improve the robustness of trial data and provide information on the health,...

    H. Fillit, S. Seleri Assunção, ... O. V. Tcheremissine in The Journal of Prevention of Alzheimer's Disease
    Article 21 June 2024
  8. Daridorexant treatment for chronic insomnia: a real-world retrospective single-center study

    Introduction

    Chronic insomnia disorder (CID) significantly impacts well-being and daily functioning. Daridorexant, a double orexin receptor blocker,...

    Mariana Fernandes, Fabio Placidi, ... Claudio Liguori in Neurological Sciences
    Article Open access 27 January 2024
  9. Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study

    Introduction

    Real-world data provide insight into how medications perform in clinical practice. The PIONEER REAL Switzerland study aimed to understand...

    Anastas Kick, Khadija M’Rabet-Bensalah, ... Gottfried Rudofsky in Diabetes Therapy
    Article Open access 19 January 2024
  10. Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study

    Background

    There have been very few real-world studies reported in the literature solely focusing on fremanezumab in Asia. This study aimed to...

    Seiya Ohtani, Narumi Watanabe, ... Tsubasa Takizawa in BMC Neurology
    Article Open access 14 November 2023
  11. Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study

    Purpose

    Data on treatments for male breast cancer patients are limited owing to rarity and underrepresentation in clinical trials. The real-world...

    Joanne L. Blum, Caroline DiCristo, ... Debu Tripathy in Breast Cancer Research and Treatment
    Article Open access 30 October 2023
  12. Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder

    Background

    Overactive bladder (OAB) is defined as urinary urgency accompanied by frequency and nocturia, with or without urge urinary incontinence...

    Roger R. Dmochowski, Eric S. Rovner, ... Matt T. Rosenberg in BMC Urology
    Article Open access 24 April 2023
  13. Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study

    Background

    Mepolizumab, the first widely available anti-interleukin 5 biologic, targets eosinophilic inflammation and has been shown in clinical...

    Kenneth R. Chapman, Kathryn Cogger, ... Christopher Licskai in Allergy, Asthma & Clinical Immunology
    Article Open access 04 February 2024
  14. Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort Study

    Background

    Levetiracetam is an anti-seizure medication (ASM) with an established safety profile. However, a potential safety signal of hypokalemia...

    Ohoud Almadani, Raseel Alroba, ... Adel A. Alrwisan in Drugs - Real World Outcomes
    Article Open access 03 June 2024
  15. The impact of menopause on antidepressant response: an explorative analysis from a real-world study

    This study endeavors to deepen our understanding of the subject matter by exploring, within a real-world sample, the impact of menopausal status on...

    Matteo Carminati, Valentina Fazio, ... Raffaella Zanardi in Archives of Women's Mental Health
    Article 08 April 2024
  16. Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China

    Introduction

    Tyrosine-kinase inhibitors (TKIs) have become the standard treatment for patients with advanced gastrointestinal stromal tumor (GIST);...

    **nhua Zhang, Peng Zhang, ... Jian Li in Advances in Therapy
    Article Open access 25 June 2023
  17. Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study

    Background

    Despite recent advancements in migraine treatment, some patients continue to endure significant disease burden. Due to the controlled...

    Charles Argoff, Steven P. Herzog, ... Fawad A. Khan in The Journal of Headache and Pain
    Article Open access 25 April 2024
  18. Panretinal photocoagulation plus intravitreal conbercept for diabetic retinopathy in real world: a retrospective study

    Background

    To evaluate outcomes of panretinal photocoagulation (PRP) plus intravitreal conbercept (IVC) for diabetic retinopathy (DR) in real world...

    **n Wang, **g Yao, ... Aiyi Zhou in BMC Ophthalmology
    Article Open access 04 October 2023
  19. Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population

    Introduction

    Biological monoclonal antibodies play a pivotal role in cancer treatment, with biosimilars significantly enhancing their accessibility....

    Debora Gagliato, Tomás Reinert, ... Vivienne Castilho in Oncology and Therapy
    Article Open access 05 June 2024
  20. Real-world experience with brolucizumab in neovascular age-related macular degeneration over 2 years: the REBA extension study

    Background

    To determine long-term efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (nAMD) in...

    Alper Bilgic, Laurent Kodjikian, ... Thibaud Mathis in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 08 December 2023
Did you find what you were looking for? Share feedback.